Table 1.
Results of laboratory and imaging studies of the patient.
| LH∗ (N < 0.05) | 0.05 mIU/mL |
| FSH∗ (N: 0.1–3) | 0.11 mIU/mL |
| Total testosterone (N: <0.14) | 0.13 ng/mL |
| TSH∗ (N: 0.7–6.4) | 1.02 mIU/mL |
| Free T4∗ (N: 0.8–2.2) | 1.17 ng/dL |
| 17OHP∗ (N: 0.03–0.9) | 0.9 ng/mL |
| Prolactin (N: 2.89–35) | 23 ng/mL |
| Cortisol (N > 9) | 13.4 mcg/dL |
| DHEA-S∗ (N: 5–57) | 17.8 mcg/dL |
| Estradiol (N < 10) | <10 pg/mL |
| SHBG∗ (N: 11.2–100) | 125.3 nmol/L |
| Bone age | 5 years 9 months |
| Beta-HCG∗ (N < 1) | 0.1 mIU/mL |
| Alpha fetoprotein (N < 9) | 0.3 ng/mL |
| Carcinoembryogenic antigen (N: 0–3) | 0.9 ng/mL |
| Scrotal ultrasonography | Right testis: 0.5 mL. 12 × 8 mm solid mass with cystic component in the central area was detected in left testis. |
| Thorax Computed Tomography | Normal |
| Abdomen Computed Tomography | Normal |
∗LH: luteinizing hormone; FSH: follicle stimulating hormone; TSH: thyroid stimulating hormone; Free T4: free tiroksin-4; 17OHP: 17-hydroxyprogesterone; DHEA-S: dehydroepiandrostenedione-sulphate; SHBG: sex-hormone-binding-globulin; Beta-HCG: beta-human chorionic gonadotropin; N: normal range.